Clinical Trial: A Study to Learn How a Single Dose of the Study Medicine Called PF-08057418 is Tolerated in the Body of Healthy Adults.

U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT07575906) titled 'A Study to Learn How a Single Dose of the Study Medicine Called PF-08057418 is Tolerated in the Body of Healthy Adults.' on May 04.

Brief Summary: The purpose of this clinical trial is to learn about the safety and pharmacokinetics (pharmacokinetics helps us understand how the drug is changed and eliminated from your body after you take it) of the study medicine (called PF-08057418) in healthy people.

This study is seeking participants who are healthy adults.

Everyone who participates in this study will receive the study medicine. The study medicine may be given as a solution or as a tablet. Participants will be dosed once a week fo...